ABLBio, Inc. operates as a drugs development company. The Company develops and manufactures neurodegenerative diseases therapeutic drugs, oncology therapeutic drugs, and other products. ABLBio markets its products throughout Korea.

Organization of Investor Relations Event

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

ABLBio (298380 KS)

Organization of Investor Relations Event

Organization of Investor Relations Event

Material Management Information related to Judgment of Investment(Grabody-B íë«í¼ ê¸°ì ì´ì ë° ê³µëê°ë° ê³ì½ ì²´ê²°)

Decision on Paid-in Capital Increase(Material Management Matters of Subsidiary Company)

Decision on Acquisition of Shares or Investment Securities of Other Corporation

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Organization of Investor Relations Event

Organization of Investor Relations Event

Material Management Information related to Judgment of Investment(Grabody-B íë«í¼ ê¸°ì ì´ì  ë° ê³µëê°ë° ê³ì½ ì²´ê²°)

Decision on Paid-in Capital Increase(Material Management Matters of Subsidiary Company)

Decision on Acquisition of Shares or Investment Securities of Other Corporation

Material Management Information related to Judgment of Investment(Grabody-B íë«í¼ ê¸°ì ì´ì ë° ê³µëê°ë° ê³ì½ ì²´ê²°)